Ads
-
Related paper
- New Oral Anticoagulants in the Treatment of Patients with Atrial Fibrillation
- Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
- ROLE OF NOVEL ORAL ANTICOAGULANTS (NOACS)IN PATIENTS WITH ATRIAL FIBRILLATION CARDIOVERSION- AN EXECUTIVE
- ROLE OF NOVEL ORAL ANTICOAGULANTS (NOACS)IN PATIENTS WITH ATRIAL FIBRILLATION CARDIOVERSION- AN EXECUTIVE SUMMARY
- PREDICTION OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION SUFFERING FROM OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME
- Different Role of Left Atrial Size and Function in Patients with Paroxysmal versus Persistent Atrial Fibrillation. Wellnhofer: LA Size & Function in Atrial Fibrillation
- Influence of Complex Treatment Including Antiplatelet Agents on the Humoral Indicators of Endothelial Dysfunction in Patients with Atrial Fibrillation
- Changes of the level of galectin-3, β-2-microglobulin, albuminuria and end glycation products in patients with chronic heart failure and atrial fibrillation under the influence of treatment
- Postoperative Atrial Fibrillation and its association with the Atrial Substrate and the electrophysiological properties of the Atrial Myocardium
- A study on clinical profile of patients with atrial fibrillation